Every imported question, contribution and motion, with its classification. Unflagged, uncertain and not-yet-analysed records are all included so the analysis can be checked independently.
To ask the Minister of Health to detail cancer waiting times within the Western Health and Social Care Trust, including how this compares with the other Trusts.
To ask the Minister of Health to detail the number of staff within the Business Services Organisation, broken down by (i) job title; and (ii) pay grade.
To ask the Minister of Health to detail the number of staff involved in the Regional Obesity Management Service, broken down by (i) job title; and (ii) pay grade.
To ask the Minister of Health to detail any steps his Department will take to improve urgent breast cancer referrals, with only 7.9 per cent of urgent breast cancer referrals currently resulting in an appointment within the 14 day target.
To ask the Minister of Health to detail (i) any considerations given to improving uptake in screening programmes for breast, bowel and cervical cancers; and (ii) whether there are any plans to expand screening programmes to include other forms of cancer.
To ask the Minister of Health to detail (i) any reasons why under 30 per cent of patients begin treatment within the 62-day target following a cancer diagnosis; and (ii) any steps that will be taken to get this to the 95 per cent target.
To ask the Minister of Health, pursuant to AQW 49072/22-27, to detail (i) any further progress to date on the full implementation of Part 5 of the Mental Capacity (Northern Ireland) Act 2016; and (ii) any steps he will take to ensure provisions related to lasting powers of attorney for health matters are fully…
To ask the Minister of Health to detail any plans his Department has to provide an interim access pathway for omaveloxolone (Skyclarys) for eligible patients with Friedreich ataxia.
To ask the Minister of Health to detail any enforcement powers that are being considered as part of the proposed retail licensing scheme for retailers selling tobacco, vaping and nicotine products, including whether licences may be suspended, revoked or made subject to conditions.
To ask the Minister of Health whether he expects any consultation on a retail licensing scheme for retailers selling tobacco, vaping and nicotine products to commence during the 2022-27 Assembly mandate.
To ask the Minister of Health to detail any work that remains to be completed before a timetable can be established for a consultation on a retail licensing scheme for retailers selling tobacco, vaping and nicotine products.
To ask the Minister of Health to detail the number of retailers that have received more than one Fixed Penalty Notice for the sale of vaping products to persons under the age of 18, in the last three years.
To ask the Minister of Health, pursuant to AQW 49437/22-27, whether any assessment has been made of the reasons why 17.7 per cent of test purchases relating to vaping products in 2024-25 resulted in a sale to a person under the age of 18.
To ask the Minister of Health whether any patient safety incidents or delayed diagnoses have occurred as a result of the backlog with Pathology Services in each of the last 24 months.
To ask the Minister of Health to detail the number of specimens sent from Pathology Services to English pathology services for processing in each of the last 24 months.
To ask the Minister of Health to detail the expected turnaround time for a specimen at Pathology Services to be processed, including the current longest wait to be processed.
To ask the Minister of Health to detail the number of specimens awaiting processing at Pathology Services, including the proportion of which are awaiting processing for cancer-related cases.
To ask the Minister of Health to detail any reasons why HER2-low metastatic breast cancer patients do not have access to the drug Enhertu as a treatment option.
To ask the Minister of Health to detail the number of drugs and treatment options that are not offered in Northern Ireland but that are approved and offered to patients in England and Wales for (i) cancer patients; and (ii) patients with a life-limiting condition.
To ask the Minister of Health whether there are any overarching plans to oversee the gaps in patient care and treatment that exist across the GB NHS, but not in Northern Ireland.